Director at SiriusPoint (NYSE: SPNT) awarded 5,903 restricted shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Mahmud Mehdi reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd director Mahmud Mehdi received a grant of 5,903 Common Shares at a reference price of $23.29 per share. This award increases his direct holdings to 123,558 Common Shares.
The position includes restricted shares scheduled to vest in full on May 30, 2027, conditional on his continued service as a director.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Mahmud Mehdi
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 5,903 | $23.29 | $137K |
Holdings After Transaction:
Common Shares — 123,558 shares (Direct, null)
Footnotes (1)
- Includes restricted shares that vest in full on May 30, 2027, subject to the Reporting Person's continued service as a director of the Company. Includes Restricted Shares.
Key Figures
Shares granted: 5,903 shares
Grant reference price: $23.29 per share
Total shares after grant: 123,558 shares
+1 more
4 metrics
Shares granted
5,903 shares
Common Shares grant on May 29, 2026
Grant reference price
$23.29 per share
Price per Common Share for the award
Total shares after grant
123,558 shares
Direct Common Share holdings following transaction
Vesting date
May 30, 2027
Restricted shares vesting, subject to continued service
Key Terms
restricted shares, vest in full, grant, award, or other acquisition, Common Shares
4 terms
vest in full financial
"restricted shares that vest in full on May 30, 2027"
grant, award, or other acquisition financial
"transaction code description: Grant, award, or other acquisition"
FAQ
What insider transaction did SiriusPoint (SPNT) report for director Mahmud Mehdi?
SiriusPoint reported that director Mahmud Mehdi received a grant of 5,903 Common Shares. The award was recorded at a reference price of $23.29 per share and is classified as a grant or other acquisition, not an open-market purchase.